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Abstract
Objective To determine the association of resting echocardiography
before elective intermediate to high risk non-cardiac surgery with survival
and length of hospital stay.
Design Population based retrospective cohort study.
Setting Acute care hospitals in Ontario, Canada, between 1 April 1999
and 31 March 2008.
Participants Patients aged over 40 years who had elective intermediate
to high risk non-cardiac surgery.
Intervention Resting echocardiography within 6 months before surgery.
Main outcome measures Postoperative survival (30 days and 1 year)
and length of hospital stay; postoperative surgical site infection as an
outcome for which no association with echocardiography would be
expected.
Results Of the 264 823 patients in the entire cohort, 15.1% (n=40 084)
had echocardiography. After use of propensity score methods to
assemble a matched cohort (n=70 996) that reduced differences between
patients who had or had not had echocardiography, echocardiography
was associated with increases in 30 day mortality (relative risk 1.14,
95% confidence interval 1.02 to 1.27), 1 year mortality (1.07, 1.01 to
1.12), and length of hospital stay but no difference in surgical site
infections (1.03, 0.98 to 1.06). The association with mortality was
influenced (P=0.02) by whether patients had had stress testing or had
risk factors for cardiac complications. No association existed between
echocardiography and mortality among patients who had stress testing
(relative risk 1.01, 0.92 to 1.11) or among patients at high risk who had
not had stress testing (1.00, 0.87 to 1.13). However, echocardiography
was associated with mortality in patients at low risk (relative risk 1.44,
1.14 to 1.82) and intermediate risk (1.10, 1.02 to 1.18) who had not had
stress testing.
Conclusions Preoperative echocardiography was not associated with
improved survival or shorter hospital stay after major non-cardiac surgery.
These findings highlight the need for further research to guide better
use of this common preoperative test.
Introduction
Perioperative cardiac complications are an important concern
for the 234 million people every year who have major surgery
worldwide.
1 Cardiac complications occur after at least 2% of
elective non-cardiac procedures and account for a third of
postoperativedeaths.
2 3Consensusbasedguidelinesrecommend
preoperative risk stratification in an attempt to prevent these
complications.
4Accurateestimatesofperioperativecardiacrisk
will identify people who may benefit from optimisation of
chronic medical treatment, interventions such as β blockade or
coronary revascularisation, aggressive haemodynamic
management, closer postoperative surveillance, or avoidance
of surgery.
As predictive indices based on readily available clinical risk
factors have limitations,
5 clinicians sometimes use specialised
cardiacteststoimproveestimationofperioperativerisk.Recent
population based studies suggest that the specialised cardiac
test most commonly ordered before major non-cardiac surgery
is resting echocardiography.
6-8 Echocardiography offers
advantages because it is readily available and does not require
intravenous injection, radioactive isotopes, or exposure to
radiation.
9 It also provides information on ventricular
dysfunctionandvalvularabnormalities,aswellasonfixedwall
motion abnormalities that suggest previous myocardial
infarction. However, some authors have suggested that
information derived from echocardiography does not provide
Corresponding to: D N Wijeysundera d.wijeysundera@utoronto.ca
Reprints: http://journals.bmj.com/cgi/reprintform Subscribe: http://resources.bmj.com/bmj/subscribers/how-to-subscribe
BMJ 2011;342:d3695 doi: 10.1136/bmj.d3695 Page 1 of 13
Research
RESEARCHadditional prognostic information when combined with readily
available clinical risk factors.
9
Given its relatively common use,
6-8 understanding whether
information derived from preoperative echocardiography
improves perioperative care and outcomes is important.
Specifically, if echocardiography results in improved clinical
outcomes, its increased use is justified. However, if it does not,
the relatively common use of echocardiography represents an
unnecessary healthcare cost that may also unnecessarily delay
scheduled surgeries. Notably, echocardiography could worsen
outcomes if it provides inaccurate prognostic information. For
example, a normal echocardiogram may provide false
reassurance of low cardiac risk. Conversely, an abnormal
echocardiogram may misclassify patients as being at high risk,
thereby exposing them to unnecessary and potentially harmful
interventions, such as perioperative β blockade.
3
No randomised controlled trial has yet evaluated the effect of
preoperativeechocardiographyonpostoperativeoutcomes.We
therefore did a population based cohort study in Ontario,
Canada,todeterminewhetherechocardiographybeforeelective
intermediate to high risk non-cardiac surgery was associated
with improved survival and shorter hospital stay.
Methods
We did a retrospective cohort study in Ontario, Canada, using
thefollowinglinkedpopulationbasedadministrativehealthcare
databases: the Discharge Abstract Database of the Canadian
Institute for Health Information (hospital admissions), the
Ontario Health Insurance Plan database (physicians’ service
claims), the Registered Persons Database (vital statistics), the
Institute for Clinical Evaluative Sciences Physician Database
(physicians’ specialties), the Ontario Drug Benefit database
(prescription drugs for people aged 65 years or older), and the
Canadian census. Although these databases lack physiological
andlaboratorymeasures,suchasbloodpressureorhaemoglobin,
they have been validated for many outcomes, exposures, and
comorbidities.
10-13Duringthestudyperiod,OntariowasCanada’s
most populous province, with more than 12 million residents,
all of whom have universal access to physicians’ and hospitals’
services through a publicly funded healthcare programme.
Cohort
Using previously described methods,
6-8 14 we identified all
Ontario residents aged 40 years or older who had the following
elective non-cardiac surgeries between 1 April 1999 and 31
March 2008: abdominal aortic aneurysm repair, carotid
endarterectomy, peripheral vascular bypass, total hip
replacement, total knee replacement, large bowel resection,
partial liver resection, Whipple procedure, pneumonectomy,
pulmonary lobectomy, gastrectomy, oesophagectomy,
nephrectomy, or cystectomy. We selected these procedures
because they carry intermediate to high risk,
4 are applicable to
both sexes, and are previously described in the Discharge
Abstract Database.
15 16 Procedural information in this database
is very accurate.
11 13 For people who had more than one eligible
procedure during the study period, we included only the first
procedure.
Using previously described methods,
17 we used the Ontario
Health Insurance Plan database to identify the principal
exposure: outpatient preoperative echocardiography
(transthoracic or transoesophageal) within 180 days before
surgery.Althoughourdatasourcescouldnotaccuratelyidentify
inpatient preoperative echocardiography, this limitation would
tendtoconservativelybiastheresultstowardsthenull.The180
daytimewindowhasbeenpreviouslyusedforresearchpurposes
and allowed for inclusion of cases in which echocardiography
may have led to preoperative coronary revascularisation.
6 18
Wefollowedpatientsforoneyearaftersurgeryfortheoutcomes
of interest—mortality and length of hospital stay. We used the
Discharge Abstract Database (in-hospital death, hospital stay)
and Registered Persons Database (deaths out of hospital) to
ascertain these outcomes. We used a one year follow-up period
to ascertain mortality because postoperative cardiac
complicationsarenotwellcapturedbyadministrativedatabases
butarecloselyassociatedwithincreasedlongtermmortality.
19 20
Demographic information came from the Registered Persons
Database,andweusedvalidatedalgorithmstoidentifydiabetes
mellitus, hypertension, and preoperative medical
consultations.
10 12 21 We used the Ontario Health Insurance Plan
database to identify any patient who needed dialysis before the
indexsurgery.UsingtheDischargeAbstractDatabase,weused
previously described methods to identify other comorbidities
on the basis of ICD-9 or ICD-10 (international classification of
diseases, 9th or 10th revision) codes from hospital admissions
within three years before surgery: coronary artery disease,
congestive heart failure, atrial fibrillation, cardiac valvular
disease (aortic or mitral stenosis), cerebrovascular disease,
peripheral vascular disease, pulmonary disease, chronic renal
insufficiency,previousvenousthromboembolism,liverdisease,
peptic ulcer disease, rheumatological disease, hemiplegia or
paraplegia, malignancy, and dementia.
22-24 We also used the
Discharge Abstract Database to identify previous mechanical
aortic or mitral valve replacement procedures within 10 years
beforesurgery.Whenassessingforcomorbidities,weusedonly
information from hospital admissions before the index surgery
to ascertain coronary artery disease, congestive heart failure,
atrial fibrillation, cerebrovascular disease, renal insufficiency,
and venous thromboembolism. Our purpose was to ensure that
postoperative complications were not misclassified as
comorbidities.
25
WeusedtheOntarioHealthInsurancePlandatabasetoidentify
preoperative cardiac stress testing (within 180 days before
surgery),
6 17 preoperative outpatient anaesthesia consultations,
7
perioperative epidural anaesthesia or analgesia (hereafter
referred to as “anaesthesia”),
14 and intraoperative invasive
monitoring. We estimated patients’ socioeconomic status on
thebasisoftheirneighbourhoodmedianincomeintheCanadian
census and determined their residence (rural versus urban) by
using Statistics Canada’s definitions.
26
Tounderstandhowechocardiographymightinfluenceoutcomes,
we used the Discharge Abstract Database to identify
preoperative cardiac interventions, and we used the Ontario
Drug Benefit database to identify outpatient prescriptions for β
blockers,statins,angiotensinconvertingenzymeinhibitors,and
angiotensinreceptorblockersinpatientsaged65yearsorolder.
Analyses
We developed a non-parsimonious multivariable logistic
regression model to estimate a propensity score for
echocardiography.
27 Clinical significance guided the initial
choice of covariates: age, sex, year, surgery, fifth of income,
residence (urban v rural), hospital’s characteristics (teaching
status and volume of procedures), comorbid disease,
preoperative medical consultation (general internist,
cardiologist), preoperative anaesthesia consultation, epidural
anaesthesia, and invasive monitoring. The comorbidities
included in the model were coronary artery disease, congestive
heart failure, atrial fibrillation, cardiac valvular disease,
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RESEARCHmechanical heart valve, cerebrovascular disease, peripheral
vascular disease, hypertension, diabetes, pulmonary disease,
renaldisease,previousvenousthromboembolism,liverdisease,
peptic ulcer disease, rheumatological disease, hemiplegia or
paraplegia, malignancy, and dementia. We used previously
describedmethodstocategorisehospitalsintoquarters,
28onthe
basis of the total volume of included procedures. We used a
structured iterative approach to refine this logistic regression
model to achieve balance of covariates within the matched
pairs.
29Weusedthestandardiseddifferencetomeasurecovariate
balance, whereby an absolute standardised difference above
10% represents meaningful imbalance.
29 We then matched
(without replacement) patients who had echocardiography to
those who did not, by using a greedy matching algorithm with
a calliper width of 0.2 SD of the log odds of the propensity
score. We used statistical methods appropriate for paired data
to compare outcomes.
29
We did subgroup analyses based on coronary artery disease,
congestive heart failure, pulmonary disease, surgery, hospital
type, concurrent cardiac stress testing, and the revised cardiac
risk index (0 points, 1-2 points, ≥3 points).
2 For these subgroup
analyses, we repeated the propensity score matching process
while simultaneously forcing a match on the subgroup
characteristics.Wethenusedlogisticregression(estimatedwith
generalised estimating equations
30 31) to assess for interactions
between the exposure and subgroups of interest. As data on
outpatient prescriptions are available only for people over 65
years of age, and we used a one year look back period to
ascertain preoperative drugs, we did an additional subgroup
analysis in patients aged over 66 years.
Totesttherobustnessofourresults,wemeasuredtheassociation
of echocardiography with an outcome for which no difference
wouldbeexpected—surgicalsiteinfection(DischargeAbstract
Database).
32 The purpose of this “tracer” analysis was to test
forresidualconfounding.Assurgicalsiteinfectionisassociated
with increased patients’ risk status,
32 but should not be
influencedbypreoperativeechocardiography,wehypothesised
that echocardiography would not be associated with increased
rates of these infections.
We used SAS version 9.2 for all analyses. We used a two tailed
P value less than 0.05 to define statistical significance.
Results
Thecohortconsistedof264823patients,ofwhom15.1%(n=40
084) had echocardiography within 180 days before surgery.
Patients who did or did not have echocardiography differed
significantly for all measured characteristics (tables 1 and 2).
Those who had echocardiography were generally older men
who had greater burdens of comorbid disease; they were more
likely to have had specialist consultations and cardiac stress
testing. Additionally, they were more likely to receive epidural
anaesthesia and intraoperative invasive monitoring.
We matched approximately 89% (n=35 498) of patients who
hadechocardiographytosimilarcontrols.Thecovariatebalance
wasconsiderablyimproved(tables3and4);themedianabsolute
standardiseddifferencedecreasedfrom12.2%(range0.5-83.4%)
to 0.4% (0-1.9%). Within the matched cohort, preoperative
echocardiography was associated with a small and statistically
significant increase in postoperative mortality, both at 30 days
(relativerisk1.14,95%confidenceinterval1.02to1.27;P=0.02;
numberneededtoharm(NNH)423)andatoneyear(1.07,1.01
to1.12;P=0.02;NNH222)(table5).Itwasalsoassociatedwith
anincreaseinmeanhospitalstay(0.31(95%confidenceinterval
0.17 to 0.44) days; P<0.001), but not surgical site infection
(relative risk 1.03, 0.98 to 1.06; P=0.18).
Patients who had echocardiography were also more likely to
have received new prescriptions for β blockers, statins,
angiotensin converting enzyme inhibitors, and angiotensin
receptorblockersbeforesurgery(table5).Conversely,theyhad
similarratesofcoronaryangiographyorcoronaryarterybypass
graftingbeforesurgeryandlowerratesofpercutaneouscoronary
intervention (table 5).
In subgroup analyses, revised cardiac risk index class and
concurrent stress testing influenced (P=0.02) the association of
echocardiography with one year mortality (table 6). Among
patients who had had stress testing, we found no association
between echocardiography and mortality (relative risk 1.01,
0.92 to 1.11). Conversely, among those who had not had stress
testing, the association of echocardiography with mortality
variedwithrevisedcardiacriskindexclass.Itwasnotassociated
withmortalityinpatientsathighrisk(revisedcardiacriskindex
3-6 points: relative risk 1.00, 0.87 to 1.13) but was associated
withincreasedmortalityamongthoseatlowrisk(0points:1.44,
1.14 to 1.82; NNH 163) and intermediate risk (1-2 points: 1.10,
1.02 to 1.18; NNH 116).
The increased mortality in these subgroups was mirrored by
qualitativelysimilarincreasesinnewprescriptionsforβblockers
and statins (table 7). Specifically, rates of new prescriptions for
β blockers and statins were relatively higher in the same
subgroups in which echocardiography was associated with
increased mortality. By comparison, concurrent stress testing
andrevisedcardiacriskindexclassdidnotinfluence(interaction
P=0.26) the association of echocardiography with new
prescriptions for angiotensin converting enzyme inhibitors and
angiotensin receptor blockers.
Discussion
In this population based cohort study, preoperative
echocardiography was frequently ordered and was associated
with statistically significant, but very small, increases in
mortality and length of hospital stay after major elective
non-cardiacsurgery.Theincreaseinmortalityvariedaccording
to whether patients had clinical risk factors for perioperative
cardiac events or had had non-invasive stress testing.
Echocardiography was not associated with any difference in
mortality among patients who also had stress testing or among
patients at high risk with three or more clinical risk factors.
However, it was associated with increased mortality among
patients at low to intermediate risk who had not had stress
testing. These subgroup specific increases in mortality were
mirrored by qualitatively similar increases in perioperative β
blockade.Conversely,ratesofcoronaryangiographyorsurgical
coronaryrevascularisationweresimilarinpatientswhohadhad
echocardiography, whereas rates of percutaneous coronary
intervention were lower.
Influence of unmeasured confounding
Especiallyinthecontextofanon-randomisedstudy,considering
whether the increased mortality after echocardiography was
simply due to residual unmeasured confounding is important.
Specifically,patientswhohadechocardiographymayhavebeen
sicker and therefore at increased risk for postoperative
complications. Despite our use of statistical methods to adjust
for these differences and excellent covariate balance within the
matchedpairs,ourdatasourcesmayhavelackedsufficientdetail
to allow adequate adjustment for risk. However, several factors
indicate that any residual confounding was small in magnitude
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RESEARCHand unlikely to have masked important benefits from
preoperativeechocardiography.Firstly,wefoundnoassociation
betweenechocardiographyandthetraceroutcome,surgicalsite
infection. Surgical site infection is unlikely to be influenced by
echocardiography. However, it is associated with markers of
increased perioperative risk,
32 which include characteristics not
capturedbyadministrativedata.Theseriskfactorsincludesome
comorbidities, such as smoking or obesity,
33 34 as well as the
severity of pre-existing diseases. Thus, if residual confounding
within the matched pairs was minimal, rates of surgical site
infection should be similar, as was the case in our study.
Secondly, we found no association between echocardiography
and mortality in patients who had concurrent stress testing.
Echocardiographyisunlikelytoprovideadditionalinformation
that will change perioperative management for such patients.
Thus, if it was associated with increased mortality in this
subgroup, echocardiography may have been a marker for
unmeasured risk factors, such as poor exercise capacity. As
would be expected in the presence of minimal residual
confounding, we found no difference in mortality. Finally,
previous studies using these same data sources have found that
perioperative interventions (such as epidural anaesthesia or
stress testing) that are preferentially used in patients at high risk
are nevertheless associated with improved outcomes after
adjustmentforrisk.
6 14Theseresultssuggestthatourdatasources
contain sufficient detail for adjustment for confounding.
Interpretation of findings
Overall,ourresultssuggestthatechocardiography,despitebeing
the most commonly ordered specialised preoperative cardiac
test, does not provide information that improves outcomes. We
found no difference in outcomes in patients at high risk or in
those who had had stress testing and worsened outcomes in
patients at low to intermediate risk who had not had stress
testing. By comparison, cardiac stress testing is associated with
decreased survival in patients at low risk but with improved
survivalinthoseatintermediatetohighrisk.
6Importantly,these
findings apply to resting echocardiography, not stress
echocardiography, which accurately stratifies perioperative
cardiacriskandisassociatedwithimprovedoutcomesincertain
subgroups.
6 35 These results are also largely consistent with
another population based study of preoperative cardiac testing
in American Medicare recipients having vascular surgery.
18
Fleisher and colleagues found that echocardiography was
associatedwithnounadjusteddifferenceinmortalitywhendone
before abdominal aortic aneurysm repair and an unadjusted
increase in mortality when done before peripheral vascular
bypass surgery.
Several plausible explanations for our findings exist. Firstly,
although echocardiography can identify systolic dysfunction,
this information has relatively poor prognostic accuracy. In a
prospective cohort study of 393 men who had blinded
echocardiography before non-cardiac surgery,
9 Halm and
colleagues concluded that echocardiography did not provide
additional prognostic information beyond known clinical risk
factors. Conversely, other researchers have concluded that
systolic dysfunction predicts worsened postoperative
outcomes.
36 37However,closerexaminationofthesestudiesalso
shows that echocardiographically derived ejection fraction
performed poorly at stratifying cardiac risk. For example, Flu
and colleagues concluded that asymptomatic ventricular
dysfunction was associated with increased risk in a prospective
cohort study of 1005 patients having vascular surgery.
36
However, asymptomatic dysfunction had a likelihood ratio for
predicting30daycardiaceventsofonly1.3,comparedwith4.2
forsymptomaticcongestiveheartfailure,whichisaknownrisk
factor.
2 Similarly, Rohde and colleagues concluded that
ventricular dysfunction was associated with increased risk in
570patientshavingnon-cardiacsurgery,butitslikelihoodratio
was relatively poor at 1.8.
37
Secondly, resting echocardiography does not perform well at
quantifying perioperative risk attributable to coronary artery
disease. It does identify fixed wall motion abnormalities that
suggestpreviousmyocardialinfarction.However,intheabsence
of inducible ischaemia, which is instead identified by stress
testing, fixed defects are not associated with increased
perioperativerisk.
38 39Theinabilityofrestingechocardiography
to identify inducible ischaemia also limits its capacity to help
totargetperioperativeβblockade,whichhasitsbestrisk-benefit
profile in people with inducible ischaemia.
40
Thirdly, echocardiography was associated with considerably
increased rates of new use of β blocker in patients at low to
intermediate risk who had not had stress testing. As
echocardiography cannot identify ideal candidates for β
blockade—namely, those with inducible ischaemia
40—this
increased rate of β blockade may, in part, have explained the
increased mortality in these same subgroups. Specifically,
perioperative β blockade caused increased mortality in the
participants in the Perioperative Ischemic Evaluation (POISE)
trial,
3 and it was associated with either harm or no effect in
patientsatlowtointermediateriskinalargecohortstudy.
41The
basis for the increased use of β blockers in these subgroups
remainsunclearandwarrantsfurtherresearch.Echocardiography
mayhaveprovidedinformationthatwasmisinterpretedandled
tounnecessaryβblockade.Forexample,βblockersmighthave
beeninstitutedonthebasisofthepresenceoffixedwallmotion
abnormalities, which are not associated with increased risk.
38 39
Conversely, aggressive ordering of both echocardiography and
perioperativeβblockade(regardlessoftheinformationderived
from the echocardiograms) in patients at low to intermediate
risk may be a characteristic of a certain type of physician’s
practice.
Finally, even when preoperative echocardiography identifies
ventriculardysfunction,clinicianshavenotreatmentsofproved
efficacy to reduce associated perioperative risks. Thus far, no
randomisedtrialshaveevaluatedperioperativemedicaltreatment
forcongestiveheartfailure.
42Previouslyevaluatedinterventions,
such as β blockers or α2 adrenergic agonists,
3 43 focused on
preventing complications related to coronary artery disease. In
ourstudy,ratesofnewprescriptionsforangiotensinconverting
enzyme inhibitors or angiotensin receptor blockers were
significantly increased among patients who had preoperative
echocardiography. These prescriptions may therefore have
representednewlyinstitutedtreatmentforasymptomaticsystolic
dysfunction identified by preoperative echocardiography.
Although these drugs are recommended for treating systolic
dysfunction in the non-operative setting,
44 their effects in the
perioperativesettingremainunknown.Ifanything,peoplehave
raised concerns about recent use of angiotensin converting
enzyme inhibitors and angiotensin receptor blockers causing
perioperative hypotension,
45 which is itself associated with
mortality.
3However,thedifferentialmortalityacrosssubgroups
in our study was not mirrored by similar differences in new
prescriptions for angiotensin converting enzyme inhibitors or
angiotensin receptor blockers, suggesting that these drugs were
not causally related to mortality.
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RESEARCHLimitations
Our study has several limitations. As an observational study, it
does not prove a causal link between echocardiography and
postoperative mortality. Our findings therefore warrant
confirmation by other multicentre studies across different
settings and data sources. These confirmatory studies should
probably include a randomised trial of routine preoperative
echocardiography, as has been done for preoperative cardiac
stress testing.
46 Such a trial is better suited to showing causal
links but will require a large sample size. Specifically, based
on a 7.5% one year mortality rate with conventional care, 9046
participants are needed to show a 20% relative risk reduction
withpreoperativeechocardiography(twosidedα=0.05and80%
power). Secondly, our administrative data sources do not
generallyidentifypostoperativecomplicationsaccurately,
19and
they have limited information on test results, inpatient drugs,
and causes of death. Such information would have helped to
explain the mechanisms by which echocardiography may
influence outcomes. These specific data should therefore be
measured by future prospective cohort studies of preoperative
echocardiography.
Finally, our data sources did not capture detailed clinical
characteristics, thereby limiting our ability to examine specific
subgroupsthatmaybenefitfrompreoperativeechocardiography.
For example, the current guidelines of the American Heart
Association and American College of Cardiology recommend
preoperative echocardiography only for people with dyspnoea
of unknown cause or recent worsening of known congestive
heartfailure.
4Similarly,echocardiographymayhelptoestablish
whether a suspicious systolic murmur is caused by previously
undiagnosedaorticstenosis.Asadministrativedatabasesdonot
capture these details, our study does not negate the role of
echocardiography in such circumstances. Overall, using
preoperative echocardiography for specific diagnostic
indications is reasonable; however, our results would suggest
that, in the absence of such indications, echocardiography does
not provide clinically useful information to improve
perioperative care.
Implications for future research
The relatively common use of preoperative echocardiography
and its lack of association with improved outcomes highlight
several additional areas for future research in perioperative
medicine. More prospective cohort studies are needed to
determine whether echocardiography provides prognostic
informationwithclinicallyusefullikelihoodratios.Thesestudies
shouldcollectdetailedmeasurementsoncharacteristicssuchas
functionalcapacitytohelptodeterminewhetheranysubgroups
derive better prognostic information. If echocardiography does
not show prognostic accuracy that is independent of
conventional and more easily measured risk factors, it is highly
unlikely to serve as useful test for guiding clinical care. In
addition, randomised trials are needed to evaluate potential
interventions, such as perioperative treatment with angiotensin
converting enzyme inhibitors or altered perioperative fluid
management, for improving the outcomes of patients with
ventriculardysfunction.Intheabsenceofprovedinterventions,
clinicianswillhavefewavenuesforimprovingclinicalcareand
outcomes on the basis of the results of preoperative
echocardiography.
Conclusions
This population based cohort study found that preoperative
echocardiography was not associated with improved survival
aftermajorelectivenon-cardiacsurgery.Ourfindingscastdoubt
on the usefulness of preoperative echocardiography for
improvingperioperativeoutcomes.Furthermore,theyhighlight
the importance of research to stratify patients’ perioperative
riskbetterandtodevelopefficaciousinterventionsthatdecrease
perioperative complications related to ventricular dysfunction.
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RESEARCHTables
Table 1| Preoperative characteristics of entire cohort. Values are numbers (percentages) unless stated otherwise
Absolute standardised difference (%) No echocardiogram (n=224 739) Echocardiogram (n=40 084)
Demographics
15.7 118 780 (52.9) 18 079 (45.1) Female sex
36.9 67.0 (10.8) 70.7 (9.5) Mean (SD) age (years)
Fifth of income:
3.6 40 604 (18.1) 7809 (19.5) First (lowest)
2.2 46 142 (20.5) 8595 (21.4) Second
0.5 44 897 (20.0) 7918 (19.8) Third
2.0 44 877 (20.0) 7690 (19.2) Fourth
3.2 47 564 (21.2) 7974 (19.9) Fifth (highest)
2.0 655 (0.3) 98 (0.2) Missing
9.0 34 405 (15.3) 4898 (12.2) Rural residence
Comorbid disease
39.2 20 712 (9.2) 9374 (23.4) Coronary artery disease
19.4 3950 (1.8) 2174 (5.4) Congestive heart failure
19.9 4830 (2.1) 2398 (6.0) Atrial fibrillation
14.1 604 (0.3) 692 (1.7) Cardiac valvular disease*
8.5 340 (0.2) 305 (0.8) Mechanical cardiac valve†
15.1 5443 (2.4) 2126 (5.3) Cerebrovascular disease
37.3 15 243 (6.8) 7647 (19.1) Peripheral vascular disease
34.3 138 374 (61.6) 30 964 (77.2) Hypertension
18.1 43 159 (19.2) 10 741 (26.8) Diabetes mellitus
2.6 1160 (0.5) 273 (0.7) Thromboembolic disease
15.2 15 873 (7.1) 4604 (11.5) Pulmonary disease
13.9 4363 (1.9) 1731 (4.3) Renal disease
2.0 2107 (0.9) 433 (1.1) Liver disease
1.5 4587 (2.0) 728 (1.8) Rheumatological disease
3.7 2273 (1.0) 580 (1.4) Peptic ulcer disease
4.8 1115 (0.5) 360 (0.9) Hemiplegia or paraplegia
1.2 1477 (0.7) 306 (0.8) Dementia
Malignancy:
3.0 42 079 (18.7) 7971 (19.9) Primary
3.3 15 380 (6.8) 2407 (6.0) Metastatic
Preoperative consultations
39.1 118 805 (52.9) 28 650 (71.5) Anaesthesiology‡
Internal medicine§:
17.9 49 447 (22.0) 11 943 (29.8) General internist
63.3 15 010 (6.7) 12 071 (30.1) Cardiologist
Preoperative testing
83.4 15 356 (6.8) 15 694 (39.2) Non-invasive stress testing¶
*History of aortic stenosis or mitral stenosis.
†Mechanical aortic valve replacement or mechanical mitral valve replacement within 10 years before index surgical procedure.
‡Outpatient consultation within 60 days before surgery.
§Consultation by general internist or cardiologist within 120 days before index surgical procedure.
21
¶Within 180 days before index surgery.
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RESEARCHTable 2| Perioperative characteristics of entire cohort. Values are numbers (percentages) unless stated otherwise
Absolute standardised difference (%) No echocardiogram (n=224 739) Echocardiogram (n=40 084)
Hospital type
1.5 74 131 (33.0) 12 943 (32.3) Teaching hospital
Procedure quarter*:
10.4 57 389 (25.5) 8458 (21.1) First (lowest)
4.2 53 198 (23.7) 10 207 (25.5) Second
4.1 55 996 (24.9) 10 692 (26.7) Third
2.0 58 156 (25.9) 10 727 (26.8) Fourth (highest)
Procedure
32.4 6115 (2.7) 4288 (10.7) Abdominal aortic aneurysm repair
24.5 5710 (2.5) 3172 (7.9) Carotid endarterectomy
14.6 7802 (3.5) 2684 (6.7) Peripheral vascular bypass
13.9 52 667 (23.4) 7143 (17.8) Total hip replacement
16.2 79 998 (35.6) 11 277 (28.1) Total knee replacement
17.1 47 153 (21.0) 5807 (14.5) Large bowel surgery
2.6 1539 (0.7) 216 (0.5) Liver resection
2.8 1358 (0.6) 171 (0.4) Whipple procedure
15.1 6560 (2.9) 2400 (6.0) Pneumonectomy or lobectomy
5.2 4547 (2.0) 1116 (2.8) Gastrectomy or oesophagectomy
2.1 8921 (4.0) 1459 (3.6) Nephrectomy
2.0 2369 (1.1) 351 (0.9) Cystectomy
Perioperative care
20.1 46 997 (20.9) 11 859 (29.6) Epidural anaesthesia
44.1 58 312 (25.9) 18 669 (46.6) Arterial line
29.6 19 693 (8.8) 7561 (18.9) Central venous line
21.0 4113 (1.8) 2321 (5.8) Pulmonary artery catheter
*Divided into quarters of approximately equal patient numbers, on basis of total volume of eligible procedures over entire study period.
28
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RESEARCHTable 3| Preoperative characteristics of matched cohort. Values are numbers (percentages) unless stated indicated
Absolute standardised difference (%) No echocardiogram (n=35 498) Echocardiogram (n=35 498)
Demographics
0.4 16 589 (46.7) 16 503 (46.5) Female sex
0.9 70.7 (9.5) 70.7 (9.6) Mean (SD) age (years)
Fifth of income:
0.3 6973 (19.6) 6931 (19.5) First (lowest)
0.2 7606 (21.4) 7567 (21.3) Second
<0.1 6993 (19.7) 7003 (19.7) Third
0.8 6755 (19.0) 6834 (19.3) Fourth
0.3 7082 (20.0) 7070 (19.9) Fifth (highest)
<0.1 89 (0.3) 93 (0.3) Missing
0.6 4421 (12.5) 4525 (12.7) Rural residence
Comorbid disease
<0.1 8021 (22.6) 8011 (22.6) Coronary artery disease
0.4 1866 (5.3) 1860 (5.2) Congestive heart failure
0.9 2084 (5.9) 2012 (5.7) Atrial fibrillation
0.9 425 (1.2) 446 (1.3) Cardiac valvular disease*
1.2 225 (0.6) 255 (0.7) Mechanical cardiac valve†
0.4 1917 (5.4) 1877 (5.3) Cerebrovascular disease
0.8 5811 (16.4) 5921 (16.7) Peripheral vascular disease
1.2 27 361 (77.1) 27 185 (76.6) Hypertension
0.7 9562 (26.9) 9451 (26.6) Diabetes mellitus
<0.1 244 (0.7) 241 (0.7) Thromboembolic disease
0.6 3987 (11.2) 3920 (11.0) Pulmonary disease
0.6 1478 (4.2) 1438 (4.1) Renal disease
<0.1 378 (1.1) 385 (1.1) Liver disease
0.7 650 (1.8) 675 (1.9) Rheumatological disease
<0.1 530 (1.5) 520 (1.5) Peptic ulcer disease
1.0 350 (1.0) 322 (0.9) Hemiplegia or paraplegia
<0.1 282 (0.8) 283 (0.8) Dementia
Malignancy:
0.8 7124 (20.1) 7027 (19.8) Primary
0.4 2162 (6.1) 2196 (6.2) Metastatic
Preoperative consultations
0.7 24 886 (70.1) 24 762 (69.8) Anaesthesiology‡
Internal medicine§:
1.3 11 170 (31.5) 10 981 (30.9) General internist
1.9 8290 (23.4) 8595 (24.2) Cardiologist
Preoperative testing
1.7 11 227 (31.6) 11 502 (32.4) Non-invasive stress testing¶
*History of aortic stenosis or mitral stenosis.
†Mechanical aortic valve replacement or mechanical mitral valve replacement within 10 years before index surgical procedure.
‡Outpatient consultation within 60 days before surgery.
§Consultation by general internist or cardiologist within 120 days before index surgical procedure.
21
¶Within 180 days before index surgery.
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RESEARCHTable 4| Perioperative characteristics of matched cohort. Values are numbers (percentages) unless stated otherwise
Absolute standardised difference (%) No echocardiogram (n=35 498) Echocardiogram (n=35 498)
Hospital type
0.2 11 969 (33.7) 12 016 (33.8) Teaching hospital
Procedure quarter*:
0.2 7313 (20.6) 7354 (20.7) First (lowest)
0.5 8635 (24.3) 8688 (24.5) Second
0.2 9559 (26.9) 9569 (27.0) Third
0.4 9991 (28.1) 9887 (27.9) Fourth (highest)
Procedure
0.7 3062 (8.6) 3128 (8.8) Abdominal aortic aneurysm repair
<0.1 2794 (7.9) 2800 (7.9) Carotid endarterectomy
0.4 2180 (6.1) 2206 (6.2) Peripheral vascular bypass
0.5 6639 (18.7) 6571 (18.5) Total hip replacement
0.4 10 554 (29.7) 10 480 (29.5) Total knee replacement
0.3 5230 (14.7) 5271 (14.8) Large bowel surgery
<0.1 172 (0.5) 189 (0.5) Liver resection
<0.1 139 (0.4) 158 (0.4) Whipple procedure
0.8 2148 (6.1) 2100 (5.9) Pneumonectomy or lobectomy
<0.1 985 (2.8) 1005 (2.8) Gastrectomy or oesophagectomy
<0.1 1296 (3.7) 1300 (3.7) Nephrectomy
<0.1 299 (0.8) 290 (0.8) Cystectomy
Perioperative care
0.2 9906 (27.9) 9932 (28.0) Epidural anaesthesia
0.2 15 718 (44.3) 15 751 (44.4) Arterial line
0.8 5836 (16.4) 5939 (16.7) Central venous line
0.4 1894 (5.3) 1914 (5.4) Pulmonary artery catheter
*Divided into quarters of approximately equal patient numbers, on basis of total volume of eligible procedures over entire study period.
28
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RESEARCHTable 5| Outcomes and processes of care in matched cohort. Values are as numbers (percentages) unless stated otherwise
Relative risk (95% CI) No echocardiogram (n=35 498) Echocardiogram (n=35 498)
Preoperative procedures*
1.05 (0.98 to 1.14) 1204 (3.4) 1267 (3.6) Coronary angiography
0.82 (0.69 to 0.97) 273 (0.8) 223 (0.6) Percutaneous coronary intervention
1.03 (0.77 to 1.40) 84 (0.2) 87 (0.2) CABG surgery
Outcomes
1.14 (1.02 to 1.27) 609 (1.7) 693 (2.0) 30 day death
1.07 (1.01 to 1.12) 2460 (6.9) 2620 (7.4) 1 year death
1.03 (0.98 to 1.06) 4570 (12.9) 4690 (13.2) 30 day surgical site infection
(n=25 755) (n=25 755) New drug use†
1.38 (1.31 to 1.46) 1916 (7.4) 2649 (10.3) β blocker
1.20 (1.11 to 1.30) 1245 (4.8) 1500 (5.8) Statin
1.49 (1.39 to 1.49) 1255 (4.9) 1867 (7.3) ACE inhibitor
1.29 (1.15 to 1.45) 492 (1.9) 635 (2.5) Angiotensin receptor blocker
1.42 (1.34 to 1.51) 1699 (6.6) 2422 (9.4) RAS blocker‡
ACE=angiotensin converting enzyme; CABG=coronary artery bypass graft; RAS=rennin-angiotensin system.
*Within 180 days before index surgery.
†Subgroup aged ≥66 years; prescription during period 1-120 days before hospital admission, but no prescription during period between 121 and 365 days before
hospital admission.
‡ACE inhibitor or angiotensin receptor blocker.
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RESEARCHTable 6| Association of preoperative echocardiography with 1 year mortality within subgroups
1 year mortality
Cohort/subgroup Interaction* Relative risk (95% CI)
NA 1.07 (1.01 to 1.12) Entire matched cohort
Subgroups
Hospital teaching status:
P=0.30 1.02 (0.94 to 1.12) Teaching
1.09 (1.01 to 1.16) Non-teaching
Hospital procedure quarter:
P=0.36 1.13 (1.01 to 1.28) First (lowest)
1.01 (0.90 to 1.12) Second
1.10 (1.00 to 1.22) Third
1.02 (0.93 to 1.13) Fourth (highest)
Age:
P=0.87 1.07 (1.01 to 1.14) <70 years
1.06 (0.96 to 1.18) ≥70 years
Coronary artery disease:
P=0.70 1.05 (0.95 to 1.15) Present
1.07 (1.01 to 1.14) Absent
Congestive heart failure:
P=0.80 1.04 (0.90 to 1.21) Present
1.07 (1.01 to 1.13) Absent
Pulmonary disease:
P=0.96 1.07 (0.96 to 1.20) Present
1.07 (1.01 to 1.14) Absent
Concurrent cardiac stress test and RCRI†:
1.01 (0.92 to 1.11) Concurrent stress test‡
No concurrent stress test:
P=0.02 1.44 (1.14 to 1.82) RCRI: 0 points
1.10 (1.02 to 1.18) RCRI: 1-2 points
1.00 (0.87 to 1.13) RCRI: ≥3 points
Procedure:
P=0.16 1.00 (0.90 to 1.12) Vascular
1.06 (1.00 to 1.13) Abdominal or thoracic
1.20 (1.04 to 1.38) Orthopaedic
RCRI=revised cardiac risk index.
*Tests whether treatment effects differed significantly between subgroups.
†Given previously described interaction between stress testing and RCRI,
6 this subgroup analysis involved exact matching on both characteristics.
‡No significant interaction (P=0.26) between the RCRI score and preoperative echocardiography among patients who had cardiac stress testing.
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RESEARCHTable 7| Association of preoperative echocardiography with new preoperative drugs* within subgroups
New statin New β blocker
Concurrent cardiac stress
test/RCRI Interaction† Relative risk (95% CI) Interaction† Relative risk (95% CI)
1.06 (0.95 to 1.18) 1.23 (1.14 to 1.33) Concurrent stress test
No concurrent stress test:
P=0.002 1.54 (1.29 to 1.86) P<0.001 1.72 (1.47 to 2.01) RCRI: 0 points
1.30 (1.14 to 1.47) 1.57 (1.41 to 1.74) RCRI: 1-2 points
1.06 (0.94 to 1.19) 1.18 (0.96 to 1.47) RCRI: ≥3 points
RCRI=revised cardiac risk index.
*Prescription during period 1-120 days before hospital admission, but no prescription during period between 121 and 365 days before hospital admission; subgroup
aged 66 years or older.
‡Tests whether treatment effects differed significantly between subgroups; no significant subgroup effect (interaction P=0.71) for association of preoperative
echocardiography with new use of angiotensin converting enzyme inhibitor or angiotensin receptor blocker.
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